At a time when biotech incubators and shared spaces are beginning to multiply in Manhattan, work on what could rank among the city’s largest biotech centers—if it can all come together—is just getting underway. According to Paul Wexler, a longtime healthcare-focused real estate broker, construction should begin next year on what is being called the […]
NYS Entity Status
NYS Filing Date
NOVEMBER 12, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2013 - NIGERIAN CAPITAL DEVELOPMENT FUND INTERNATIONAL LIMITED LIABILITY COMPANY
Around the Web
- Near The East River, Plans Emerge For NY’s Next Life Science Center
By Ben Fidler - Monday Aug 21, 2017
- 'Mashable' Hires Bankers To Raise Capital, Explore Possible Sale
Thursday Aug 17, 2017
The company is considering strategic options that may include a sale. In March, the company announced a $15 million funding round led by Time Warner's Turner Broadcasting. Mashable said it would usethe funding and partnership to develop video.
- With Pitches for HQ2 Made, Cities Wait on Amazon’s 2018 Decision
By David Holley - Thursday Oct 19, 2017
From Portland to Pittsburgh, it’s likely that every city in the U.S. with more than 1 million people has made its case to Amazon to locate the company’s second headquarters there. At least, hopefully they have already, because today—if you haven’t heard—was the deadline to apply. Amazon sent North America into a frenzy after announcing […]
- Bill and Hillary Clinton's Hamptons Summer Rental Sells
Tuesday Aug 29, 2017
In East Hampton, N.Y., the property was sold by real estate developer Elie Hirschfeld, president of Hirschfeld Properties.
- Martin Shkreli is found guilty of fraud
By Stephanie Clifford and Colin Moynihan - Friday Aug 4, 2017
NEW YORK — Martin Shkreli, accused of defrauding his hedge fund investors and a pharmaceutical company, was convicted on three of eight counts on Friday, after a five-week trial in U.S. District Court in Brooklyn, N.Y.Shkreli was accused of securities and wire fraud related to two hedge funds he ran, MSMB Capital and MSMB Healthcare.The prosecution brought forth an “avalanche” of evidence, as prosecutor Jacquelyn Kasulis put it in her rebuttal argument, that included a threatening letter he sent to the wife of a former employee, statements he sent to MSMB investors showing great returns at the same time he had no money in fund accounts, three versions of a backdated agreement to make it look as if MSMB Capital had invested in Retrophin when it had not, as well as claims about assets under management that were wildly out of line with his actual fund size.